Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer

Comparison of 2 new real‐time polymerase chain reaction–based urinary markers in the follow‐up of patients with non–muscle‐invasive bladder cancer

(2020) Emanuela Trenti et al.   CANCER CYTOPATHOLOGY

Loss of GATA6 expression promotes lymphatic metastasis in bladder cancer

(2020) Chanjuan Wang et al.   FASEB JOURNAL

Diagnostic accuracy, clinical utility and influence on decision making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer

(2019) David D'Andrea et al.   BJU INTERNATIONAL

DNA Methylation Markers for Breast Cancer Detection in the Developing World

(2019) Bradley Downs et al.   CLINICAL CANCER RESEARCH

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

(2019) Marko Babjuk et al.   EUROPEAN UROLOGY

Noninvasive Detection and Localization of Genitourinary Cancers Using Urinary Sediment DNA Methylomes and Copy Number Profiles

(2019) Zhengzheng Xu et al.   EUROPEAN UROLOGY

Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study

(2018) Run-Qi Guo et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Urine cell-based DNA methylation classifier for monitoring bladder cancer

(2018) Antoine G. van der Heijden et al.   Clinical Epigenetics

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018

(2018) Marcus George Kwesi Cumberbatch et al.   EUROPEAN UROLOGY

Long Noncoding RNA LBCS Inhibits Self-Renewal and Chemoresistance of Bladder Cancer Stem Cells through Epigenetic Silencing of SOX2

(2018) Xu Chen et al.   CLINICAL CANCER RESEARCH

DNA hypermethylation within TERT promoter upregulates TERT expression in cancer

(2018) Donghyun D. Lee et al.   JOURNAL OF CLINICAL INVESTIGATION

Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy

(2017) Kim E.M. van Kessel et al.   JOURNAL OF UROLOGY

FGFR3 , TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study

(2017) Willemien Beukers et al.   JOURNAL OF UROLOGY

Prospective evaluation of fluorescence in situ hybridization for diagnosing urothelial carcinoma

(2017) Tianhai Lin et al.   Oncology Letters

Economic Burden of Bladder Cancer Across the European Union

(2016) Jose Leal et al.   EUROPEAN UROLOGY

Epigenetic Determinants of Cancer

(2016) Stephen B. Baylin et al.   Cold Spring Harbor Perspectives in Biology

Evaluation of urovysion and cytology for bladder cancer detection

(2013) Haythem Dimashkieh et al.   CANCER CYTOPATHOLOGY

Genome-wide Methylation Profiles Reveal Quantitative Views of Human Aging Rates

(2012) Gregory Hannum et al.   MOLECULAR CELL

Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers

(2011) T. Reinert et al.   CLINICAL CANCER RESEARCH

Identification and Validation of the Methylated TWIST1 and NID2 Genes through Real-Time Methylation-Specific Polymerase Chain Reaction Assays for the Noninvasive Detection of Primary Bladder Cancer in Urine Samples

(2009) Isabelle Renard et al.   EUROPEAN UROLOGY

Epigenetics in Cancer

(2008) Manel Esteller   NEW ENGLAND JOURNAL OF MEDICINE